Table 1.
Study | Sample size | Subjects | Control group | Age |
---|---|---|---|---|
Gauthier et al.15 | 54 subjects 31 controls | Healthy elderly with asymptomatic WMH | Young healthy volunteers | Subjects: 63 ± 5 Controls: 24 ± 3 |
Richiardi et al.16 | 20 AD 15 MCI 28 controls | AD and MCI | Healthy elderly | AD: 76 ± 7 MCI: 71 ± 10 Controls 73 ± 7 |
Conijn et al.17 | 49 | Patients with history of vascular events or cardiovascular risk factors | None | 58.9 ± 10 |
Yezhuvath et al.18 | Subjects: 12 Controls: 13 | AD | Healthy elderly | Subjects: 70.5 ± 8.3 Controls: 68.7 ± 8.4 |
Hund-Georgiadis et al.19 | Subjects: 5 Young Controls: 6 Older Controls: 6 | Stroke and ‘cerebral microangiopathy’ (white matter MRI signal changes.) | Young healthy volunteers and older healthy volunteers | Subjects: 61.8 (54–67) Young controls: 24.8 (23–27) Older controls: 57 (51–63) |
AD: Alzheimer’s disease, MCI: mild cognitive impairment.
Patient characteristics of included studies of CVR in cerebral SVD.